Figure 2From: Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study Distribution of infliximabserum trough levels and HACA-formation during the infusion interval.Back to article page